Expert perspectives with Gregory Cheng, MD, PhD

This independent medical education activity features an expert interview with Gregory Cheng, MD, PhD, focusing on important data from a recent publication that reported results of the RAISE Trial, a randomized, phase III study investigating local standard of care plus eltrombopag for treating patients with chronic immune thrombocytopenia (ITP).
Cheng G, et al. Lancet. 2010;377(9763):393-402.
Dept of Error. Lancet. 2010;377(9763):382.

Dr Cheng briefly discusses the rationale for the development of eltrombopag for chronic ITP, as well as the efficacy, tolerability, and safety of eltrombopag when used in patients with chronic ITP.